Published in Br Heart J on September 01, 1991
Amiodarone management of junctional ectopic tachycardia after cardiac surgery in children. Br Heart J (1994) 0.91
A Low-Cost Simulation Model for R-Wave Synchronized Atrial Pacing in Pediatric Patients with Postoperative Junctional Ectopic Tachycardia. PLoS One (2016) 0.75
Management of postoperative junctional ectopic tachycardia in pediatric patients: a survey of 30 centers in Germany, Austria, and Switzerland. Eur J Pediatr (2017) 0.75
Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study. Circulation (1990) 1.92
Relationship between electrocardiogram and electrolytes. Am Heart J (1967) 1.53
Diagnosis and management of postoperative junctional ectopic tachycardia. Am Heart J (1989) 1.03
Junctional ectopic tachycardia in children: electrocardiography, electrophysiology and pharmacologic response. Am J Cardiol (1979) 1.02
Hypothermia for the treatment of postsurgical greatly accelerated junctional ectopic tachycardia. J Am Coll Cardiol (1987) 0.98
Can accelerated atrioventricular junctional escape rhythms be explained by delayed afterdepolarizations? Am J Cardiol (1980) 0.96
Postoperative arrhythmias in patients with congenital heart disease. Chest (1984) 0.91
His bundle tachycardia--arrhythmogenic and antiarrhythmic effects of therapy. Eur Heart J (1987) 0.91
Usefulness of intravenous propafenone for control of postoperative junctional ectopic tachycardia. Am J Cardiol (1987) 0.91
Junctional tachycardia in infants and children after open heart surgery for congenital heart disease. Am J Cardiol (1987) 0.90
Ventricular paired pacing to control rapid ventricular heart rate following open heart surgery. Observations on ectopic automaticity. Report of a case in a four-month-old patient. Circulation (1976) 0.86
Junctional automatic ectopic tachycardia: new proposed treatment by transcatheter His bundle ablation. Am Heart J (1983) 0.85
Atypical tamponade after cardiac operation in infants and children. J Thorac Cardiovasc Surg (1982) 0.84
Junctional ectopic tachycardia in an infant: electrophysiologic evaluation. Am Heart J (1985) 0.80
Side effects of long-term amiodarone therapy. Circulation (1983) 3.03
Echocardiographic measurement of the normal adult right ventricle. Br Heart J (1986) 2.16
Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study. Br Heart J (1979) 2.06
Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. Br Heart J (1980) 1.64
Acute and chronic haemodynamic and electrophysiological effects of nifedipine in patients receiving atenolol. Br Heart J (1983) 1.52
Catheter ablation for successful management of left posterior fascicular tachycardia: an approach guided by recording of fascicular potentials. Heart (1996) 1.47
Ventricular tachycardia of left bundle branch block configuration in patients with isolated right ventricular dilatation. Clinical and electrophysiological features. Br Heart J (1984) 1.42
Clinical anatomy of the atrioventricular junctions. J Am Coll Cardiol (1994) 1.41
Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children. Br Heart J (1989) 1.40
Side effects and possible contraindications of amiodarone use. Am Heart J (1983) 1.40
Successful radiofrequency ablation of accessory pathways with the first energy delivery: the anatomic and electrical characteristics. Eur Heart J (1996) 1.38
Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest (1995) 1.37
Rapid and safe termination of supraventricular tachycardia in children by adenosine. Lancet (1987) 1.35
Amiodarone therapy during pregnancy. Am J Cardiol (1983) 1.35
Treatment of refractory supraventricular arrhythmias with flecainide acetate. Arch Dis Child (1987) 1.28
Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. Am J Cardiol (1984) 1.26
Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol (1995) 1.26
The relationship between posture, blood pressure and electrophysiological properties in patients with paroxysmal supraventricular tachycardia. Arch Mal Coeur Vaiss (1978) 1.25
Low energy catheter ablation of a posteroseptal accessory pathway associated with a diverticulum of the coronary sinus. Pacing Clin Electrophysiol (1991) 1.23
Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. Br Heart J (1980) 1.20
Endocardial pacing in infants and children 15 kg or less in weight: medium-term follow-up. Pacing Clin Electrophysiol (1990) 1.13
Electrophysiological manifestations of non-penetrating cardiac trauma. Br Heart J (1980) 1.12
Concealed pre-excitation. J Electrocardiol (1978) 1.11
Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1999) 1.11
Radiofrequency catheter ablation of Mahaim tachycardia by targeting Mahaim potentials at the tricuspid annulus. Br Heart J (1995) 1.10
Localization of accessory pathways from the 12-lead electrocardiogram using a new algorithm. Am J Cardiol (1994) 1.09
Alcohol catheter ablation of atrioventricular conduction. Br Heart J (1991) 1.07
Amiodarone: the experience of the past decade. Br Med J (Clin Res Ed) (1983) 1.04
Coronary venous aneurysms and accessory atrioventricular connections. Br Heart J (1988) 1.00
Role of calcium antagonists in cardiovascular therapy. Br Heart J (1981) 0.98
Dispersion of monophasic action potential duration: demonstrable in humans after premature ventricular extrastimulation but not in steady state. J Am Coll Cardiol (1992) 0.97
Treatment of superior vena cava obstruction secondary to pacemaker wires with balloon venoplasty and insertion of metallic stents. Eur Heart J (2002) 0.96
Circadian variation of malignant ventricular arrhythmias in patients with ischemic and nonischemic heart disease after cardioverter defibrillator implantation. European 7219 Jewel Investigators. J Am Coll Cardiol (1999) 0.93
Symptomatic improvement after radiofrequency catheter ablation for typical atrial flutter. Heart (2001) 0.92
A new low energy power source for catheter ablation. Pacing Clin Electrophysiol (1986) 0.92
Right ventricular abnormalities in ventricular tachycardia of right ventricular origin: relation to electrophysiological abnormalities. Br Heart J (1986) 0.91
Histopathological findings in three children with His bundle tachycardia occurring subsequent to cardiac surgery. Eur Heart J (1992) 0.90
Prediction of atrioventricular block during radiofrequency ablation of the slow pathway of the atrioventricular node. Circulation (1995) 0.90
Catheter ablation without fulguration: design and performance of a new system. Pacing Clin Electrophysiol (1989) 0.89
Low-energy ablation of accessory pathways in cases for which the radiofrequency approach had failed. Am J Cardiol (1993) 0.89
Low energy catheter ablation of right ventricular outflow tract tachycardia. Br Heart J (1991) 0.88
The plasma atrial natriuretic peptide response to treatment of acute cardiac failure, spontaneous supraventricular tachycardia and induced re-entrant tachycardia in man. J Hypertens Suppl (1986) 0.88
Low energy internal cardioversion of atrial fibrillation resistant to transthoracic shocks. Heart (1996) 0.88
Primary ventricular fibrillation is associated with increased paced right ventricular electrogram fractionation. Circulation (1995) 0.88
Local abnormalities of right ventricular depolarization after repair of tetralogy of Fallot: a basis for ventricular arrhythmia. Am J Cardiol (1985) 0.86
Effect of multisite pacing on ventricular coordination. Heart (2002) 0.86
Calcium-channel blockers and beta blockers: advantages and disadvantages of combination therapy in chronic stable angina pectoris. Am Heart J (1982) 0.86
Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms. Eur Heart J (1995) 0.86
Electrophysiologic and antiarrhythmic actions of bepridil. Comparison with verapamil and ajmaline for atrioventricular reentrant tachycardia. Am J Cardiol (1985) 0.86
The Wolff-Parkinson-White syndrome: the cellular substrate for conduction in the accessory atrioventricular pathway. Eur Heart J (1994) 0.85
Dual-demand pacing for refractory atrioventricular re-entry tachycardia. Pacing Clin Electrophysiol (1979) 0.85
Use of troponin-T concentration and kinase isoforms for quantitation of myocardial injury induced by radiofrequency catheter ablation. Eur Heart J (1997) 0.85
Long-term follow up of patients treated with a software based antitachycardia pacemaker. Br Heart J (1993) 0.84
Effects of intravenous adenosine on verapamil-sensitive "idiopathic" ventricular tachycardia. Am J Cardiol (1994) 0.83
Impedance changes during catheter ablation and their relationship to electrical arcing and clinical efficacy. Pacing Clin Electrophysiol (1989) 0.83
Paediatric use of flecainide in supraventricular tachycardia: clinical efficacy and pharmacokinetics. Br Heart J (1989) 0.83
Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium. Heart (2001) 0.82
Intracardiac contrast echoes during transvenous His bundle ablation. Br Heart J (1985) 0.82
Comparison between biventricular pacing and single site pacing in patients with poor ventricular function: a hemodynamic study. Pacing Clin Electrophysiol (2003) 0.82
Electrical restitution in the endocardium of the intact human right ventricle. Br Heart J (1992) 0.81
Relation between atrioventricular pathways and ventricular response during atrial fibrillation and flutter. Br Heart J (1981) 0.81
Myocardial injury induced by radiofrequency and low energy ablation: a quantitative study of CK isoforms, CK-MB, and troponin-T concentrations. Pacing Clin Electrophysiol (1998) 0.81
Assessment of a prototype implantable cardioverter for ventricular tachycardia. Relation between synchronisation of sensing and origin of the tachycardia. Br Heart J (1984) 0.80
The tricuspid valve: an unusual site of endocardial pacemaker lead fracture. Pacing Clin Electrophysiol (1989) 0.80
Clinical competence in electrophysiological techniques. Heart (1997) 0.80
Maze 3 for atrial fibrillation: two cuts too few? Pacing Clin Electrophysiol (1994) 0.80
Radiofrequency catheter ablation of accessory atrioventricular pathways: primary failure and recurrence of conduction. Heart (1997) 0.80
Is vagal innervation to the atrioventricular node impaired after radiofrequency ablation of the slow atrioventricular nodal pathway? Pacing Clin Electrophysiol (1996) 0.79
Wolff-Parkinson-White syndrome: atrial fibrillation as the presenting arrhythmia. Br Heart J (1988) 0.79
Hemodynamic effects of nifedipine given alone and in combination with atenolol in patients with impaired left ventricular function. Am J Cardiol (1985) 0.79
Relationship of the effective refractory period and monophasic action potential duration after a step increase in pacing frequency. Pacing Clin Electrophysiol (1990) 0.78
A comparison of bepridil with amiodarone in the treatment of established atrial fibrillation. Br Heart J (1987) 0.78
Amiodarone for the conversion of established atrial fibrillation and flutter. Br J Clin Pract Suppl (1986) 0.78
Is the pulse in atrial fibrillation irregularly irregular? Br Heart J (1986) 0.78
Acceleration of the ventricular response to atrial flutter by amiodarone in an infant with Wolff-Parkinson-White syndrome. Br Heart J (1993) 0.78
Electrical ablation of junctional tachycardias showing a long RP interval. Eur Heart J (1989) 0.77
QT dispersion and triple-vessel coronary disease. Lancet (1997) 0.77
Effects of intravenous adenosine in patients with preexcited junctional tachycardias: therapeutic efficacy and incidence of proarrhythmic events. Am J Cardiol (1994) 0.77
Performance of basic ventricular tachycardia detection algorithms in implantable cardioverter defibrillators: implications for device programming. Pacing Clin Electrophysiol (1997) 0.77
Use of flecainide in children. Lancet (1989) 0.76
'Bradycardia-tachycardia' syndrome 8 yr after correction of Fallot's tetralogy. Eur J Cardiol (1979) 0.76
Audit of implantable cardioverter-defibrillators in a single UK centre. BMJ (1999) 0.75
Wolff-Parkinson-White syndrome: inadvertent permanent ablation of the accessory pathway during electrophysiological study. Br Heart J (1988) 0.75
The automatic implantable cardioverter/defibrillator for a life threatening arrhythmia in a case of post-partum cardiomyopathy. Postgrad Med J (1989) 0.75
Impact of catheter and surgical ablation on arrhythmia treatment in a tertiary referral centre. Br Heart J (1992) 0.75
Endocavitary ablation of atrioventricular conduction. Br Heart J (1990) 0.75
Successful intracardiac electrical conversion of atrial flutter in patients with complex congenital heart disease. Br Heart J (1991) 0.75
Fifty years of tachycardia. Br Heart J (1995) 0.75
Latent pre-excitation: exposure of anterograde accessory pathway conduction during atrial fibrillation. Br Heart J (1988) 0.75
Effects of intravenous dofetilide on induction of atrioventricular re-entrant tachycardia. Heart (2001) 0.75
Restrictive transmitral filling patterns predict improvements in left ventricular function after biventricular pacing. Heart (2003) 0.75
QRS waveforms in right and left bundle-branch aberration. Br Heart J (1980) 0.75
Familial ventricular tachycardia: a report of four families. Br Heart J (1990) 0.75
Low-energy DC catheter ablation of left atrial ectopic tachycardia that had resulted in reversible cardiomyopathy. Pacing Clin Electrophysiol (1993) 0.75
Characteristics of bipolar electrograms during anterograde mapping: the importance of accessory atrioventricular pathway location. Am Heart J (1996) 0.75
Electrophysiological effects of E 4031, a drug with selective class III properties, in man. Pacing Clin Electrophysiol (1997) 0.75
Antigen and immune complex induced suppression of delayed hypersensitivity. Adv Exp Med Biol (1976) 0.75
Nonpharmacological treatment of supraventricular tachycardia. Rev Port Cardiol (1992) 0.75
Sudden cardiac death while taking amiodarone therapy: the role of abnormal repolarization. Eur Heart J (1991) 0.75